S4 Medical Meets Primary Endpoint in Esophagus Deviation During Radiofrequency Ablation of Atrial Fibrillation (EASY AF Study)

CLEVELAND, September 12, 2022 (Newswire.com) - S4 Medical Corp, an Ohio-based company with technology originating from The Ohio State University, announced that it is stopping the Esophagus Deviation During Radiofrequency Ablation of Atrial Fibrillation (EASY AF) Study due to successful... Read More